[1] Kvles P S, Williams D L, Hendrta M, et al. Patien sarisfaction after anesthesia and surgery:Results of a prospective survey of 10811 patients[J]. Br F Anaesth 2000, 84(1):6-10. [2] Kovac A L.Prevention and treatment of postoperative nausea and vomiting[J]. Drugs, 2000,59(2):213-243. [3] Gold B, Kitz D S, Lecky J H.Unanticipated admission to the hospital following ambulatory surger [J].FAMA, 1989, 262(21):3008-3010. [4] Lee A F.循证临床麻醉学[M]. 北京:人民卫生出版社,2007:117. [5] 李科珍.3种止吐药物对卵巢癌患者TP化疗所致恶心呕吐的抑制作用[J].药物与临床, 2011, 10(30):1301. [6] 刘学胜.手术后恶心呕吐的研究进展[J] .国际麻醉学与复苏,2005, 26(5):286. [7] 蒋煌.恩丹西酮合用地塞米松预防腹腔镜胆囊切除术后恶心呕吐临床应用[J].中外健康文摘, 2011, 12(8):127. [8] 陈新.新编药物学[M]. 17版,北京:人民卫生出版社,2011:492. [9] 宋晓坤. 5-HT 3 受体拮抗药治疗化疗性呕吐的临床应用概述[J].中国药师, 2012, 15(4):563. [10] Schwartzberg L, Jackson J, Jain G, et al. Impact of 5-HT 3 RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting[J].Expert Rea Pharmacoecon Outcomes Res, 2011, 11(4):481-488. [11] 狄万军.浅谈5-羟色胺受体拮抗剂对胃肠道不良反应的治疗[J].世界新医学信息文摘,2013, 13(22):216. [12] 罗美娟.2013年北京、成都、广州、上海四城市5-羟色胺受体拮抗剂应用分析[J].中国医院用药评价与分析,2015,15(6):774. [13] 方向志. 5-羟色按受体拮抗剂与氟哌利多预防术后恶心呕吐效果的Meta分析[J].国际麻醉学与复苏杂志, 2015, 3(36):225. [14] 谭欣.不同5-HT 3 受体拮抗剂预防腹腔镜术后恶心呕吐的临床观察[J].比较哲学,2014, 11(35):345. [15] 吕德生.手术前后应用5-HT 3 受体拮抗剂对全麻术后恶心和呕吐预防效果的Mate分析[J].江苏大学学报(医学版), 2011, 21 (3):269-272. |